Maria Vittoria Hospital Report issue

Academic/Hospital Phase 4
Founded: Turin Italy (1958)

Organization Overview

First Clinical Trial
2005
NCT00128427
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Cardiology Department. Maria Vittoria Hospital. ASL 3 Torino | Cardiology Department. Maria Vittoria Hospital. ASL 3. Torino. | Cardiology Department. Maria Vittoria Hospital. ASL3 Torino. | Cardiology Department. Maria Vittoria Hospital. ASL 3 Torino (Coordinating Center) | Cardiology Department. Maria Vittoria Hospital. ASL 3 Torino (Coordinating Center). | Cardiology Department. Maria Vittoria Hospital, ASL 3 Torino. Italy. | Cardiology Dpt.Maria Vittoria Hospital, Torino, Italy | Hospital Maria Vittoria, Turin, Italy | Massimo Imazio

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Atrial Fibrillation (Phase 3)

Delirium (Phase 4)

Hypoxia (Phase 4)

Hypoxia, Brain (Phase 4)

Pericardial Effusion (Phase 3)

Pericarditis (Phase 4)

Pleural Effusion (Phase 3)

Postpericardiotomy Syndrome (Phase 3)

Recurrence (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 4